Altered amyloid precursor protein (APP) processing and amyloid β (Aβ) production have long been implicated in the cognitive decline associated with age-related neurological disorders such as Alzheimer’s disease (AD) [1] and HIV-associated neurocognitive disorders (HAND) [2–4]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.